Net Income

Tel Aviv's stock exchange reports unprecedented 2025 growth, fueled by strategic global outreach, a booming IPO market, and remarkable market resilience.

A new report predicts 3.1 million Ontarians will have a major illness by 2040, revealing regional disparities and straining an already fragile system.

TNS Associates marks its 43rd anniversary with a local ranking, shining a light on Denver's booming estate planning market and modern business awards.

VIO Med Spa is using an advanced training university to standardize excellence, drive rapid franchise growth, and define the future of aesthetic medicine.

Newsweek honors a Bronx facility for its quality care, but the award highlights the complex reality families face when navigating the world of long-term care.

MDClone launches ADAMS Copilot, a GenAI tool letting clinicians analyze data with simple questions, all while keeping sensitive information safe on-site.

Amid a 400% surge in ransomware targeting SAP, Onapsis and partners like Microsoft will tackle the security crisis driven by AI and cloud adoption.

A new multi-year deal gives RNAi leader Alnylam access to Helix's vast genomic and clinical data, aiming to redefine the speed of drug discovery.

February saw 3.8 billion robocalls, a yearly drop. But a rise in daily call rates and massive scam campaigns show the fight is far from over.

A new study reveals ER burnout isn't just from long hours, but from chaotic patient intake. Can an AI co-pilot be the antidote for exhausted clinicians?

WEBTOON elevates Yongsoo Kim to President, a strategic move to tackle slowing growth and accelerate innovation after a challenging post-IPO period.

As AI adoption outpaces oversight, Check Point’s new advisory service aims to help enterprises manage risk and navigate complex new regulations like the EU AI Act.

A new partnership is pioneering a data-driven family engagement platform, setting a new standard for pediatric health and digital transformation.

At MWC26, iFLYTEK launched ambitious AI translation glasses, but faces stiff competition from Google and Alibaba, along with lingering privacy questions.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?

CIBC's move to pay back $1B in debentures five years ahead of schedule highlights its strong liquidity and proactive capital management strategy.

A new survey reveals over half of Americans delay healthcare, creating a 'health debt' crisis fueled by cost fears and scheduling conflicts for younger generations.

A new partnership between Always and The Fibroid Foundation aims to break the silence on heavy periods and fibroids, combining product innovation with advocacy.

With book value soaring, Stack Capital offers a rare public window into the massive valuations of private titans like SpaceX and the AI infrastructure boom.

Taiwanese biotech GNTbm's oral drug GNTbm-38, which turns 'cold' tumors 'hot', will begin Phase 1 trials for advanced and refractory cancers.